X0306
4
2016-10-31
0000884905
PRAXAIR INC
PX
0001595290
Roby Anne K
C/O PRAXAIR, INC.
39 OLD RIDGEBURY ROAD
DANBURY
CT
06810-5113
0
1
0
0
Senior Vice President
Common Stock
897.6568
I
401(k)
Common Stock
2016-10-31
4
M
0
5103
83.89
A
19337
D
Common Stock
2016-10-31
4
S
0
5103
117.37
D
14234
D
Common Stock
2016-10-31
4
M
0
2897
83.89
A
17131
D
Common Stock
2016-10-31
4
M
0
12000
83.89
A
29131
D
Common Stock
2016-10-31
4
S
0
12000
117.41
D
17131
D
Stock Option (right to buy)
83.89
2016-10-31
4
M
0
5103
0
D
2009-02-26
2018-02-26
Common Stock
5103
2897
D
Stock Option (right to buy)
83.89
2016-10-31
4
M
0
2897
0
D
2009-02-26
2018-02-26
Common Stock
2897
0
D
Stock Option (right to buy)
83.89
2016-10-31
4
M
0
12000
0
D
2009-02-26
2018-02-26
Common Stock
12000
0
D
Stock Option (right to buy)
76.16
2011-02-23
2020-02-23
Common Stock
10230
10230
D
Stock Option (right to buy)
97.84
2012-02-22
2021-02-22
Common Stock
13195
13195
D
Stock Option (right to buy)
109.68
2013-02-28
2022-02-28
Common Stock
18430
18430
D
Stock Option (right to buy)
110.58
2014-02-26
2023-02-26
Common Stock
15790
15790
D
Stock Option (right to buy)
128.80
2015-02-25
2024-02-25
Common Stock
19900
19900
D
Stock Option (right to buy)
128.38
2016-02-24
2025-02-24
Common Stock
26490
26490
D
Stock Option (right to buy)
102.22
2017-02-23
2026-02-23
Common Stock
49405
49405
D
Deferred Stock
0
Common Stock
4071.236
4071.236
D
The $117.37 price reported is the weighted average sale price. The sale prices ranged from $117.30 to $117.415 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
The $117.41 price reported is the weighted average sale price. The sale prices ranged from $117.30 to $117.60 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
This option vests over three years in three consecutive equal annual installments beginning on February 24, 2016.
This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.
Conversion to Praxair Common Stock is on a 1-for-1 basis.
Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Plan as amended ("Deferral Plan") and are to be settled in Praxair Common Stock.
Anthony M. Pepper, Attorney-in-Fact
2016-11-02